Home Health Chapter scores $42M for Medicare navigation platform; Quris rakes in $28M and...

Chapter scores $42M for Medicare navigation platform; Quris rakes in $28M and different digital well being fundings

0

Digital Medicare advisor Chapter landed $42 million in a Sequence B funding spherical led by Addition, with participation from Narya Capital, Susa Ventures, Maverick Ventures, XYZ Enterprise Capital, Core Innovation Capital and Health2047 Capital Companions.

The corporate is ready to assist employers work with their staff on switching their plans to Medicare. Sufferers can use the platform to navigate the Medicare system. 

As of at the moment, the corporate has a complete of $61 million in funding.  


Scientific prediction software program firm Quris nabbed $28 million in seed-funding spherical led by Welltech Ventures, with participation from iAngels and GlenRock Capital. 

The brand new money is anticipated to assist increase the staff, and assist area novel drug R&D efforts. The instrument’s scientific AI prediction platform is at the moment working with companions on drug growth for Fragile X syndrome (FXS). 

“Now could be the time to faucet know-how to rework drug growth and finish the pricey cycle of failed scientific trials,” Quris CEO Isaac Bentwich mentioned in a press release. “The added investor assist will assist Quris develop the staff and partnerships wanted to create a transparent view to foretell the scientific security of medicine for particular person sufferers. With the know-how advances at our disposal, we will shut the scientific prediction hole.”


Maternity-focused digital well being firm Diana Well being scored $11 million in a Sequence A funding spherical led by LRVHealth and .406 Ventures, with participation from AlleyCorp. The brand new funds shall be used to assist the startup launch its first location.

The corporate companions with hospitals to deliver tech-backed companies to sufferers and clinicians digital sources to personalize the maternity journey.  

“The care we obtain as girls, significantly throughout being pregnant and delivery, has the potential to impression inhabitants well being throughout generations whereas constructing lifelong connections between a household and their healthcare supplier,” Kate Condliffe, cofounder and CEO of Diana Well being, mentioned in a press release.

“Conventional care fashions could make it difficult for suppliers to embrace this chance. That’s why we’re fully restructuring care packages to supply partaking, complete well being assist that may drive significant change within the lives of girls and households.”


Boston-based startup PostEra scored $24 million in Sequence A funding for its machine studying preclinical drug discovery know-how. The spherical was led by Clermont Group with participation from Breyer Capital, Lifeforce Capital and I2BF World Ventures, in addition to current traders. 

The brand new funds will go in the direction of serving to the corporate proceed to develop its medicinal chemistry platform, in addition to staff up with different firms and start its personal drug discovery. 

“PostEra has made massive strides in demonstrating the true utility of our AI-first medicinal chemistry platform to speed up small molecule drug discovery,” Aaron Morris, CEO of PostEra, mentioned in a press release. “We’ve a confirmed report in deploying our machine studying know-how to unify the Design-Make-Check cycle of medicinal chemistry and vastly enhance upon conventional trial-and-error based mostly approaches.”


Senior-focused insurtech firm the Helper Bees introduced a $12.8 million Sequence B funding spherical. Belief Ventures led the spherical, with participation from Silverton Companions, Northwestern Mutual Fund Ventures, Influence Engine and Congress Avenue Ventures. 

The corporate is targeted on serving to seniors age in place. The corporate works with an individual’s insurance coverage firm to supply information analytics and tech-backed companies, in addition to streamlined insurance coverage claims. 


Ianacare, a Boston-based startup centered on supporting caregivers, landed $12.1 million in Sequence A funding, in line with TechCrunch.

The service lets caregivers create social circles of family and friends members to assist with each day duties. It helps hyperlink customers to advantages and native sources, and additionally supplies teaching. 


Digital self-neuromodulation remedy firm GrayMatters Well being introduced a $10 million Sequence A funding spherical. Otsuka Medical Units led the funding spherical. 

The Israeli firm is targeted on treating psychological well being circumstances. It makes use of ECG and fMRI information to create an individual’s EEP (Electrical Fingerprint) biomarker. The system consists of an EEG-neurofeedback system that may assist regulate a affected person’s EFP biomarker, in line with its web site. 

“GrayMatters is introducing the primary digital therapeutic system that instantly targets and regulates particular mind biomarkers related to psychological issues, whereas digitizing current remedy strategies concentrate on mitigating the ensuing signs and behaviors,” mentioned Oded Kraft, GrayMatters Well being cofounder and CEO.

“This funding spherical will assist GrayMatters Well being full its scientific investigation, get hold of clearance from regulatory authorities and launch Prism for PTSD in america. It additionally helps our collaboration with McLean Hospital, the most important psychiatric affiliate of Harvard Medical Faculty and a member of Mass Basic Brigham. Collectively we plan to conduct a scientific investigation to find out Prism’s efficacy and security as an adjunct remedy for Main Depressive Dysfunction (MDD) with anhedonia.”


Digital scientific trial platform CRIO scored $9 million in Sequence B funding. Abbhi Capital led the spherical, with participation from Rally Ventures and NXT Ventures. This new funding spherical brings the corporate’s complete elevate to $15.7 million. 

The brand new infusion of money will go in the direction of increasing the product, engineering and business-development groups. The Boston-based firm works with a variety of healthcare stakeholders to assist streamline regulatory workflows and seize scientific information.